Mepolizumab

Common brands: Nucala, Prednisone, Prednisone Delayed Release, Prednisone Tablets, Usp, 10 Mg, Prednisone Tablets, Usp, 20 Mg

Top reporter: Glaxosmithkline Llc

Interleukin-5 Antagonist [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]Vitamin C [EPC]
48,288
Total Reports
31,714
Serious Reports
3,745
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.76%)

Patient Demographics

Male
11,343
Female
23,887

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Mepolizumab.

# Reaction Reports % of Total
1 ASTHMA 12,635
12.0%
2 DYSPNOEA 10,418
9.9%
3 WHEEZING 7,036
6.7%
4 PRODUCT DOSE OMISSION ISSUE 6,427
6.1%
5 COUGH 5,038
4.8%
6 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5,004
4.7%
7 PNEUMONIA 4,535
4.3%
8 DRUG INEFFECTIVE 4,521
4.3%
9 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4,206
4.0%
10 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3,090
2.9%
11 OFF LABEL USE 3,004
2.8%
12 FATIGUE 2,998
2.8%
13 MALAISE 2,710
2.6%
14 CONDITION AGGRAVATED 2,670
2.5%
15 HEADACHE 2,619
2.5%
16 PAIN 2,425
2.3%
17 PRODUCTIVE COUGH 2,279
2.2%
18 NASOPHARYNGITIS 2,178
2.1%
19 OBSTRUCTIVE AIRWAYS DISORDER 2,158
2.0%
20 HOSPITALISATION 2,061
2.0%
21 CHEST DISCOMFORT 1,963
1.9%
22 ARTHRALGIA 1,887
1.8%
23 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1,819
1.7%
24 FULL BLOOD COUNT ABNORMAL 1,798
1.7%
25 DEATH 1,759
1.7%
26 RASH 1,742
1.7%
27 DIZZINESS 1,662
1.6%
28 ACCIDENTAL EXPOSURE TO PRODUCT 1,620
1.5%
29 LUNG DISORDER 1,616
1.5%
30 LOWER RESPIRATORY TRACT INFECTION 1,603
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.